Watermark
  Back to Search Results

BGB-16673-302

Recruiting

A Study of BGB-16673 Compared to Investigator’s Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-16673-302

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06846671

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2024-518893-15-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents